Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807375981> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2807375981 endingPage "e211" @default.
- W2807375981 startingPage "e211" @default.
- W2807375981 abstract "Objective: Acute heart failure (AHF) remains a major health concern, with high mortality and re-hospitalization rates and treatment being still largely opinion-based. Resolvins (Rvs), derived from omega-3-fatty acids, actively contribute to the resolution of inflammation and tissue regeneration and recent experimental findings suggest that their administration improves cardiac function after myocardial infarction. However, they remain scarcely explored in clinical settings of AHF. Therefore, we aimed to evaluate serum RvD1 and RvE1, and to determine their correlation with biomarkers of cardiac injury/dysfunction, proinflammatory/redox status and endothelial dysfunction in AHF. Design and method: Patients with the diagnosis of AHF (n = 10) and cardiogenic shock (CS) (n = 9) were included and blood samples were collected at admission and at days 3 to 5. Blood donors were used as controls (n = 10). RvD1, RvE1, nitrotyrosine (redox dysfunction biomarker) and endocan (endothelial dysfunction biomarker) were measured with ELISA kits. C-reactive protein (CRP), B-type natriuretic peptide, high-sensitivity troponin I and leukocyte count were evaluated using automated analyzers. Results: RvD1 values on admission were significantly higher in AHF than in CS (AHF: 2.98 ± 0.42 ng/mL vs CS: 1.39 ± 0.24ng/mL, p = 0.024) although there were no significant differences compared to controls values (controls: 1.84 ± 0.34; p = ns vs AHF or CS). On the other hand, RvE1 concentration on admission was significantly increased in patients with AHF and with CS (controls: 0.076 ± 0.018; AHF: 0.19 ± 0.040 ng/mL; CS: 0.23 ± 3.8ng/mL; controls vs AHF, p = 0.048; controls vs CS, p = 0.007). Furthermore, there was a significant trend for a linear increase between controls, AHF and CS (p = 0.003). There were no significant changes between Rvs values on admission and on later time points. We only observed positive correlations between RvE1 and CRP (r = 0.342, p = 0.041), neutrophil-to-lymphocyte ratio (r = 0.472, p = 0.006), nitrotyrosine (r = 0.395, p = 0.007) and endocan (r = 0.346, p = 0.018). Conclusions: These Rvs have distinct profiles in AHF, with RvE1 increasing with the severity of the clinical/hemodynamical condition in CS patients and being significantly associated with inflammatory/redox status and endothelial dysfunction. In contrast, RvD1, whose administration has been shown to be cardioprotective in experimental myocardial infarction, appears to be exhausted or inactivated in worse clinical scenarios in the spectra of AHF." @default.
- W2807375981 created "2018-06-13" @default.
- W2807375981 creator A5017617232 @default.
- W2807375981 creator A5033378866 @default.
- W2807375981 creator A5039718670 @default.
- W2807375981 creator A5054223710 @default.
- W2807375981 creator A5056102682 @default.
- W2807375981 creator A5060767599 @default.
- W2807375981 creator A5070297265 @default.
- W2807375981 creator A5084089641 @default.
- W2807375981 date "2018-06-01" @default.
- W2807375981 modified "2023-09-27" @default.
- W2807375981 title "INFLAMMATION RESOLUTION MEDIATORS IN ACUTE HEART FAILURE" @default.
- W2807375981 doi "https://doi.org/10.1097/01.hjh.0000539595.60360.5f" @default.
- W2807375981 hasPublicationYear "2018" @default.
- W2807375981 type Work @default.
- W2807375981 sameAs 2807375981 @default.
- W2807375981 citedByCount "1" @default.
- W2807375981 countsByYear W28073759812019 @default.
- W2807375981 crossrefType "journal-article" @default.
- W2807375981 hasAuthorship W2807375981A5017617232 @default.
- W2807375981 hasAuthorship W2807375981A5033378866 @default.
- W2807375981 hasAuthorship W2807375981A5039718670 @default.
- W2807375981 hasAuthorship W2807375981A5054223710 @default.
- W2807375981 hasAuthorship W2807375981A5056102682 @default.
- W2807375981 hasAuthorship W2807375981A5060767599 @default.
- W2807375981 hasAuthorship W2807375981A5070297265 @default.
- W2807375981 hasAuthorship W2807375981A5084089641 @default.
- W2807375981 hasConcept C126322002 @default.
- W2807375981 hasConcept C164027704 @default.
- W2807375981 hasConcept C164705383 @default.
- W2807375981 hasConcept C185592680 @default.
- W2807375981 hasConcept C2775846464 @default.
- W2807375981 hasConcept C2775915353 @default.
- W2807375981 hasConcept C2776252253 @default.
- W2807375981 hasConcept C2776850375 @default.
- W2807375981 hasConcept C2776914184 @default.
- W2807375981 hasConcept C2778198053 @default.
- W2807375981 hasConcept C2780972559 @default.
- W2807375981 hasConcept C2781197716 @default.
- W2807375981 hasConcept C2781300812 @default.
- W2807375981 hasConcept C500558357 @default.
- W2807375981 hasConcept C55493867 @default.
- W2807375981 hasConcept C71924100 @default.
- W2807375981 hasConcept C78085059 @default.
- W2807375981 hasConcept C90924648 @default.
- W2807375981 hasConceptScore W2807375981C126322002 @default.
- W2807375981 hasConceptScore W2807375981C164027704 @default.
- W2807375981 hasConceptScore W2807375981C164705383 @default.
- W2807375981 hasConceptScore W2807375981C185592680 @default.
- W2807375981 hasConceptScore W2807375981C2775846464 @default.
- W2807375981 hasConceptScore W2807375981C2775915353 @default.
- W2807375981 hasConceptScore W2807375981C2776252253 @default.
- W2807375981 hasConceptScore W2807375981C2776850375 @default.
- W2807375981 hasConceptScore W2807375981C2776914184 @default.
- W2807375981 hasConceptScore W2807375981C2778198053 @default.
- W2807375981 hasConceptScore W2807375981C2780972559 @default.
- W2807375981 hasConceptScore W2807375981C2781197716 @default.
- W2807375981 hasConceptScore W2807375981C2781300812 @default.
- W2807375981 hasConceptScore W2807375981C500558357 @default.
- W2807375981 hasConceptScore W2807375981C55493867 @default.
- W2807375981 hasConceptScore W2807375981C71924100 @default.
- W2807375981 hasConceptScore W2807375981C78085059 @default.
- W2807375981 hasConceptScore W2807375981C90924648 @default.
- W2807375981 hasIssue "Supplement 1" @default.
- W2807375981 hasLocation W28073759811 @default.
- W2807375981 hasOpenAccess W2807375981 @default.
- W2807375981 hasPrimaryLocation W28073759811 @default.
- W2807375981 hasRelatedWork W2328354663 @default.
- W2807375981 hasRelatedWork W2355594703 @default.
- W2807375981 hasRelatedWork W2359620487 @default.
- W2807375981 hasRelatedWork W2377825901 @default.
- W2807375981 hasRelatedWork W2381143126 @default.
- W2807375981 hasRelatedWork W2383671142 @default.
- W2807375981 hasRelatedWork W2390396046 @default.
- W2807375981 hasRelatedWork W2779222010 @default.
- W2807375981 hasRelatedWork W3155674270 @default.
- W2807375981 hasRelatedWork W3187572025 @default.
- W2807375981 hasVolume "36" @default.
- W2807375981 isParatext "false" @default.
- W2807375981 isRetracted "false" @default.
- W2807375981 magId "2807375981" @default.
- W2807375981 workType "article" @default.